Photofrin approved in U.K. for palliative treatment of esophageal cancer and late-stage lung cancer Jan. 7, 1999
Angiogene's vascular-targeting agent for solid tumors enters Zeneca's development portfolio Jan. 5, 1999
IND filed by Cell Pathways for new SAAND; lead compound Prevatac enters clinic for sixth indication Dec. 30, 1998
RSS